Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2013-02-04

FDA Approved: ADVIL PM — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application to Advil PM for labeling updates related to the combination of diphenhydramine HCl and ibuprofen (sleep aid and pain rel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVIL PM (DIPHENHYDRAMINE HCL; IBUPROFEN)

Snippet

SUPPL AP for ADVIL PM (DIPHENHYDRAMINE HCL, IBUPROFEN)